Weight reduction modulates expression of genes involved in extracellular matrix and cell death: The GENOBIN study

International Journal of Obesity

Volumn 32, Issue 2, 2008, Pages 292-303

  Kolehmainen, M ^a   Salopuro, T ^a   Schwab, U S ^a,b   Kekalainen J ^a   Kallio, P ^a   Laaksonen, D E ^a,b   Pulkkinen, L ^a   Lindi, V I ^a   Sivenius, K ^a   Mager, U ^a   Siitonen, N ^a   Niskanen, L ^b   Gylling, H ^a,b   Rauramaa, R ^a,b   Uusitupa, M ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

Author keywords

Adipose tissue; Extracellular matrix; Gene expression profile; Insulin resistance; Weight reduction

Indexed keywords

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; CELL DEATH; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXTRACELLULAR MATRIX; FEMALE; GENE CLUSTER; GENE EXPRESSION; GENE IDENTIFICATION; GLUCOSE METABOLISM; HUMAN; HUMAN TISSUE; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; MALE; METABOLIC SYNDROME X; NUCLEOTIDE SEQUENCE; OBESITY; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; UNINDEXED SEQUENCE; WEIGHT REDUCTION;

ADULT; AGED; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CELL DEATH; EXTRACELLULAR MATRIX; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; WEIGHT LOSS;

EID: 39449106720     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803718     Document Type: Article

References (54)

1. Uusitupa M. Gene-diet interaction in relation to the prevention of obesity and type 2 diabetes: evidence from the Finnish Diabetes Prevention Study. Nutr Metab Cardiovasc Dis 2005; 15: 225-233.
2. Eckel RH, Grundy SM, Zimmet PZ. The metabolic syndrome. Lancet 2005; 365: 1415-1428.
3. Moller DE, Kaufman KD. Metabolic syndrome: a clinical and molecular perspective. Annu Rev Med 2005; 56: 45-62.
4. Laaksonen DE, Lakka HM, Niskanen LK, Kaplan GA, Salonen JT, Lakka TA. Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. Am J Epidemiol 2002; 156: 1070-1077.
5. Laaksonen DE, Niskanen L, Lakka HM, Lakka TA, Uusitupa M. Epidemiology and treatment of the metabolic syndrome. Ann Med 2004; 36: 332-346.
6. Uusitupa M, Lindi V, Louheranta A, Salopuro T, Lindström J, Tuomilehto J, Finnish Diabetes Prevention Study Group. Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study. Diabetes 2003; 52: 2532-2538.
7. Kahn SE. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia 2003; 46: 3-19.
8. Osei K, Rhinesmith S, Gaillard T, Schuster D. Impaired insulin sensitivity, insulin secretion, and glucose effectiveness predict future development of impaired glucose tolerance and type 2 diabetes in pre-diabetic African Americans: implications for primary diabetes prevention. Diabetes Care 2004; 27: 1439-1446.
9. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, Ilanne-Parikka P et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001; 344: 1343-1350.
10. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002; 346: 393-403.
11. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997; 20: 537-544.
12. Kloting N, Berndt J, Kralisch S, Kovacs P, Fasshauer M, Schon MR et al. Vaspin gene expression in human adipose tissue: association with obesity and type 2 diabetes. Biochem Biophys Res Commun 2006; 339: 430-436.
13. Marrades MP, Milagro FI, Martinez JA, Moreno-Aliaga MJ. Differential expression of aquaporin 7 in adipose tissue of lean and obese high fat consumers. Biochem Biophys Res Commun 2006; 339: 785-789.
14. Nordström EA, Ryden M, Backlund EC, Dahlman I, Kaaman M, Blomqvist L et al. A human-specific role of cell death-inducing DFFA (DNA fragmentation factor-alpha)-like effector A (CIDEA) in adipocyte lipolysis and obesity. Diabetes 2005; 54: 1726-1734.
15. Large V, Arner P. Regulation of lipolysis in humans. Pathophysiological modulation in obesity, diabetes, and hyperlipidaemia. Diabetes Metab 1998; 24: 409-418.
16. Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H et al. Recent advances in the relationship between obesity, inflammation, and insulin resistance. Eur Cytokine Netw 2006; 17: 4-12.
17. Trayhurn P, Bing C, Wood IS. Adipose tissue and adipokines - energy regulation from the human perspective. J Nutr 2006; 136: 1935S-1939S.
18. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett 2006; 580: 2917-2921.
19. Viguerie N, Vidal H, Arner P, Holst C, Verdich C, Avizou S et al. Adipose tissue gene expression in obese subjects during low-fat and high-fat hypocaloric diets. Diabetologia 2005; 48: 123-131.
20. Arvidsson E, Viguerie N, Andersson I, Verdich C, Langin D, Arner P. Effects of different hypocaloric diets on protein secretion from adipose tissue of obese women. Diabetes 2004; 53: 1966-1971.
21. Cancello R, Henegar C, Viguerie N, Taleb S, Poitou C, Rouault C et al. Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005; 54: 2277-2286.
22. Rasmussen M, Belza A, Almdal T, Toubro S, Bratholm P, Astrup A et al. Change in beta1-adrenergic receptor protein concentration in adipose tissue correlates with diet-induced weight loss. Clin Sci (London) 2005; 108: 323-329.
23. Kolehmainen M, Vidal H, Alhava E, Uusitupa MI. Sterol regulatory element binding protein 1c (SREBP-1c) expression in human obesity. Obes Res 2001; 9: 706-712.
24. Gomez-Ambrosi J, Catalan V, Diez-Caballero A, Martinez-Cruz LA, Gil MJ, Garcia-Foncillas J et al. Gene expression profile of omental adipose tissue in human obesity. FASEB J 2004; 18: 215-217.
25. Lee YH, Nair S, Rousseau E, Allison DB, Page GP, Tataranni PA et al. Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: increased expression of inflammation-related genes. Diabetologia 2005; 48: 1776-1783.
26. Dahlman I, Linder K, Arvidsson Nordstrom E, Andersson I, Liden J, Verdich C et al. Changes in adipose tissue gene expression with energy-restricted diets in obese women. Am J Clin Nutr 2005; 81: 1275-1285.
27. Clement K, Viguerie N, Poitou C, Carette C, Pelloux V, Curat CA et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004; 18: 1657-1669.
28. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult treatment panel III). JAMA 2001; 285: 2486-2497.
29. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Curr Opin Cardiol 2006; 21: 1-6.
30. Sarkkinen E, Schwab U, Niskanen L, Hannuksela M, Savolainen M, Kervinen K et al. The effects of monounsaturated-fat enriched diet and polyunsaturated-fat enriched diet on lipid and glucose metabolism in subjects with impaired glucose tolerance. Eur J Clin Nutr 1996; 50: 592-598.
31. Boston RC, Stefanovski D, Moate PJ, Sumner AE, Watanabe RM, Bergman RN. MINMOD Millennium: a computer program to calculate glucose effectiveness and insulin sensitivity from the frequently sampled intravenous glucose tolerance test. Diabetes Technol Ther 2003; 5: 1003-1015.
32. Ohisalo JJ, Kaartinen JM, Ranta S, Mustajoki P, Hreniuk SP, LaNoue KF et al. Weight loss normalizes the inhibitory effect of N6-(phenylisopropyl)adenosine on lipolysis in fat cells of massively obese human subjects. Clin Sci (London) 1992; 83: 589-592.
33. Rodbell M. Metabolism of isolated fat cells. I. Effects of hormones on glucose metabolism and lipolysis. J Biol Chem 1964; 239: 375-380.
34. Li C, Hung Wong W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol 2001; 2: research0032.1-research0032.11, Published online 3 August 2001.
35. Li C, Hung Wong W. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci 2001; 98: 31-36.
36. Kaput J, Rodriguez RL. Nutritional genomics: the next frontier in the postgenomic era. Physiol Genomics 2004; 16: 166-177.
37. Higami Y, Barger JL, Page GP, Allison DB, Smith SR, Prolla TA et al. Energy restriction lowers the expression of genes linked to inflammation, the cytoskeleton, the extracellular matrix, and angiogenesis in mouse adipose tissue. J Nutr 2006; 136: 343-352.
38. Martin A, Komada MR, Sane DC. Abnormal angiogenesis in diabetes mellitus. Med Res Rev 2003; 23: 117-145.
39. Hayden MR, Sowers JR, Tyagi SC. The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded. Cardiovasc Diabetol 2005; 4: 9-29.
40. Vaziri ND, Xu ZG, Shahkarami A, Huang KT, Rodriguez-Iturbe B, Natarajan R. Role of AT-1 receptor in regulation of vascular MCP-1, IL-6, PAI-1, MAP kinase, and matrix expressions in obesity. Kidney Int 2005; 68: 2787-2793.
41. Chavey C, Mari B, Monthouel MN, Bonnafous S, Anglard P, Van Obberghen E et al. Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation. J Biol Chem 2003; 278: 11888-11896.
42. Guan H, Arany E, van Beek JP, Chamson-Reig A, Thyssen S, Hill DJ et al. Adipose tissue gene expression profiling reveals distinct molecular pathways that define visceral adiposity in offspring of maternal protein-restricted rats. Am J Physiol Endocrinol Metab 2005; 288: E663-E673.
43. Wang P, Keijer J, Bunschoten A, Bouwman F, Renes J, Mariman E. Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: a role for transcriptional regulation of processing. Diabetologia 2006; 49: 2453-2462.
44. Prins JB, O'Rahilly S. Regulation of adipose cell number in man. Clin Sci 1997; 92: 3-11.
45. Prins JB, Walker NI, Winterford CM, Cameron DP. Human adipocyte apoptosis occurs in malignancy. Biochem and Biophys Res Commun 1994; 205: 625-630.
46. Ishiko O, Sumi T, Yoshida H, Hyun Y, Ogita S. Comparison of expression of apoptosis regulatory proteins in the adipose tissue of tumor-bearing and diet-restricted rabbits. Internatl JMol Med 2001; 8: 543-547.
47. Yang MU, Presta E, Bjorntorp P. Refeeding after fasting in rats: effects of duration of starvation and refeeding on food efficiency in diet-induced obesity. Am J Clin Nutr 1990; 51: 970-978.
48. Prins JB, Niesler CU, Winterford CM, Bright NM, Siddle K, O'Rahilly S et al. Tumor necrosis factor-α induces apoptosis of human adipose cells. Diabetes 1997; 46: 1939-1944.
49. Ulloa L, Messmer D. High-mobility group box 1 (HMGB1) protein: friend and foe. Cytokine Growth Factor Rev 2006; 17: 189-201.
50. Shukunami C, Oshima Y, Hiraki Y. Molecular cloning of tenomodulin, a novel chondromodulin-I related gene. Biochem Biophys Res Commun 2001; 280: 1323-1327.
51. Oshima Y, Shukunami C, Honda J, Nishida K, Tashiro F, Miyazaki J et al. Expression and localization of tenomodulin, a transmembrane type chondromodulin-I-related angiogenesis inhibitor, in mouse eyes. Invest Ophthalmol Vis Sci 2003; 44: 1814-1823.
52. Oshima Y, Sato K, Tashiro F, Miyazaki J, Nishida K, Hiraki Y et al. Anti-angiogenic action of the C-terminal domain of tenomodulin that shares homology with chondromodulin-I. J Cell Sci 2004; 117: 2731-2744.
53. Docheva D, Hunziker EB, Fassler R, Brandau O. Tenomodulin is necessary for tenocyte proliferation and tendon maturation. Mol Cell Biol 2005; 25: 699-705.
54. Tolppanen AM, Pulkkinen L, Kolehmainen M, Schwab U, Lindström J, Tuomilehto J, et al., for the Finnish Diabetes Prevention Study Group. Tenomodulin gene variations associate with adiposity and risk of diabetes - the DPS study. Obesity 2007; 15: 1082-1088.